These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 15566991)
1. The imperative for family planning in ART therapy in Africa. Shelton JD; Peterson EA Lancet; 2004 Nov 27-Dec 3; 364(9449):1916-8. PubMed ID: 15566991 [No Abstract] [Full Text] [Related]
2. HIV-infected women in ART programmes. Myer L; Morroni C; Nachega J; Cooper D Lancet; 2005 Feb 19-25; 365(9460):655-6. PubMed ID: 15721468 [No Abstract] [Full Text] [Related]
3. Sexual and reproductive health in HIV serodiscordant couples. Makwe CC; Giwa-Osagie OF Afr J Reprod Health; 2013 Dec; 17(4 Spec No):99-106. PubMed ID: 24689321 [TBL] [Abstract][Full Text] [Related]
4. The real challenges for scaling up ART in sub-Saharan Africa. Van Damme W; Kober K; Laga M AIDS; 2006 Mar; 20(5):653-6. PubMed ID: 16514294 [No Abstract] [Full Text] [Related]
5. Integrating family planning and prevention of mother-to-child HIV transmission in resource-limited settings. Duerr A; Hurst S; Kourtis AP; Rutenberg N; Jamieson DJ Lancet; 2005 Jul 16-22; 366(9481):261-3. PubMed ID: 16023518 [No Abstract] [Full Text] [Related]
6. Will ART rollout in Africa drive an epidemic of drug resistant HIV? Hastings IM; Lalloo D; Khoo SH AIDS; 2006 Jun; 20(9):1354-6; author reply 1356-7. PubMed ID: 16816578 [No Abstract] [Full Text] [Related]
7. The right of children in developing countries to be born and live HIV-free. Binagwaho A Health Hum Rights; 2008; 10(1):149-52. PubMed ID: 20845837 [No Abstract] [Full Text] [Related]
8. Continued correspondence 'Will ART rollout in Africa drive an epidemic of drug-resistant HIV?'. Hastings IM; Lalloo DG; Khoo SH AIDS; 2007 Jan; 21(2):258-9; author reply 259-60. PubMed ID: 17197825 [No Abstract] [Full Text] [Related]
9. Antiretroviral therapy in low-resource settings. Cainelli F; Lanzafame M; Vento S Lancet; 2010 Oct; 376(9750):1392. PubMed ID: 20971363 [No Abstract] [Full Text] [Related]
10. The obstetric face and challenge of HIV/AIDS. Guidozzi F; Black V Clin Obstet Gynecol; 2009 Jun; 52(2):270-84. PubMed ID: 19407534 [TBL] [Abstract][Full Text] [Related]
11. The costs and benefits of Option B+ for the prevention of mother-to-child transmission of HIV. Gopalappa C; Stover J; Shaffer N; Mahy M AIDS; 2014 Jan; 28 Suppl 1():S5-14. PubMed ID: 24468947 [TBL] [Abstract][Full Text] [Related]
12. Antiretroviral treatment and the health workforce in South Africa: how have ART workers been affected by scaling up? Tobi P; George G; Schmidt E; Renton A Trop Med Int Health; 2008 Dec; 13(12):1452-8. PubMed ID: 18983271 [TBL] [Abstract][Full Text] [Related]
13. Safety and effectiveness of antiretroviral drugs during pregnancy, delivery and breastfeeding for prevention of mother-to-child transmission of HIV-1: the Kesho Bora Multicentre Collaborative Study rationale, design, and implementation challenges. Kesho Bora Study Group Contemp Clin Trials; 2011 Jan; 32(1):74-85. PubMed ID: 20854932 [TBL] [Abstract][Full Text] [Related]
14. Family planning choices for women with HIV. Richey C; Setty V Popul Rep L; 2007 Aug; (15):1, 3-23. PubMed ID: 17974162 [No Abstract] [Full Text] [Related]
16. Unmet need for contraception among clients of FP/HIV integrated services in Nigeria: the role of partner opposition. Okigbo CC; McCarraher DR; Gwarzo U; Vance G; Chabikuli O Afr J Reprod Health; 2014 Jun; 18(2):134-43. PubMed ID: 25022150 [TBL] [Abstract][Full Text] [Related]
17. In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy. O'Brien DP; Sauvageot D; Zachariah R; Humblet P; AIDS; 2006 Oct; 20(15):1955-60. PubMed ID: 16988517 [TBL] [Abstract][Full Text] [Related]
18. Antiretroviral agents--how best to protect infants from HIV and save their mothers from AIDS. Coovadia H N Engl J Med; 2004 Jul; 351(3):289-92. PubMed ID: 15247337 [No Abstract] [Full Text] [Related]
19. Resistance at virological failure using boosted protease inhibitors versus nonnucleoside reverse transcriptase inhibitors as first-line antiretroviral therapy--implications for sustained efficacy of ART in resource-limited settings. Hill A; McBride A; Sawyer AW; Clumeck N; Gupta RK J Infect Dis; 2013 Jun; 207 Suppl 2():S78-84. PubMed ID: 23687293 [TBL] [Abstract][Full Text] [Related]
20. Barriers to contraception among HIV-positive women in a periurban district of Uganda. Mbonye AK; Hansen KS; Wamono F; Magnussen P Int J STD AIDS; 2012 Sep; 23(9):661-6. PubMed ID: 23033523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]